US Stock Market Move | Mobia Medical (MOBI.US) debuts on the US stock market with an 18% decline at the opening.
As of the time of writing, the stock has fallen by 18%, closing at $12.3.
On Friday, Mobia Medical (MOBI.US) debuted on the US stock market. As of the time of writing, the stock has dropped by 18%, trading at $12.3. The IPO price was $15. Mobia Medical is a US medical technology company based in Austin, Texas, focusing on the development of neurostimulation therapy and stroke rehabilitation devices. The company's core product, Vivistim, is a vagus nerve stimulation system used for chronic ischemic stroke rehabilitation. It is the first implantable neurostimulation device approved by the FDA to help stroke patients recover upper limb motor function.
Related Articles
Annual revenue exceeding 3 billion, is Cathay Biotech Inc. (688065.SH) truly a scarce target?
"Lumentum standing in the light" breaks into Nasdaq 100! AI data center rushes into the "optical interconnection era"
PUYI standard first quarter list revealed: Bank of Bohai's three "fixed income +" products ranked among the top five.
Annual revenue exceeding 3 billion, is Cathay Biotech Inc. (688065.SH) truly a scarce target?
"Lumentum standing in the light" breaks into Nasdaq 100! AI data center rushes into the "optical interconnection era"
PUYI standard first quarter list revealed: Bank of Bohai's three "fixed income +" products ranked among the top five.
